ArticlePharmaceuticals (Basel, Switzerland)2023

Design, Synthesis, and Evaluation of Niclosamide Analogs as Therapeutic Agents for Enzalutamide-Resistant Prostate Cancer.

Borui Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.